Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
PREVALENCE STUDY AND REGULAR PRACTICE (DIAGNOSIS AND TREATMENT) AMONG GENERAL PRACTICIONERS IN POPULATIONS AT RISK OF COPD IN LATIN AMERICA
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men or women aged more or equal than 40
Current or former smokers and/or patients exposed to biomass combustion:
Cigarettes: more or equal than 10 packs/year; Pipes: more or equal than 50 pipes/year; Cigars: more or equal than 50 cigars/year; Combustion: more or equal 100 hours/firewood/year
You may not be if
Pregnancy
Patients with contraindications for spirometry
Physical or mental disability rendering the patient unable to undergo a spirometry test and to contribute data to the study
Heart rate ≥ 120 beats by minute
Patients currently undergoing treatment for tuberculosis
A patient who is participating in an interventional clinical trial or was previously included in this study
Clareo Health | Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America
